Skip to content

Study on the correlation between senile hip fracture and bone turnover markers in urine

Study on the correlation between senile hip fracture and bone turnover markers in urine

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041264
Enrollment
Unknown
Registered
2020-12-23
Start date
2020-12-20
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture

Interventions

Elderly patients with hip fracture vs. elderly patients with osteoporosis without fracture and healthy people :Nil

Sponsors

Beijing Shijitan Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Elderly patients with hip fracture as the experimental group, elderly patients with osteoporosis without fracture and healthy people as the control group (diagnostic criteria reference guide); 2. The elderly patients were older than 60 years; 3. BMI is between 18 and 37 (as close as possible).

Exclusion criteria

Exclusion criteria: 1. Including medical symptoms affect bone metabolism, such as teenagers or premenopausal idiopathic osteoporosis, hyperthyroidism, hyperparathyroidism and a longer fixed time (> 3 months), chronic drug use, alcoholism, chronic gastrointestinal diseases, chronic kidney injury significantly (CKD IV and V), significant chronic liver injury, serious neuropathic disease, instability of cardiovascular disease or uncontrolled high blood pressure; 2. Pharmacological doses of adrenal or anabolic steroids, estrogens, antacids, anticonvulsants, anticoagulants, vitamin A, fluoride, bisphosphonates, calcitonin, tamoxifen or parathyroid hormone (PTH) in the past 6 months of any chronic treatment; 3. Glione; 4. The fracture is not acute (as determined by history, radiography, and MRI screening of the spinal cord); 5. Patients with pathological fracture (i.e. rupture caused by local tumor, tumor-like lesion or focal decalcification visible on X-ray film).

Design outcomes

Primary

MeasureTime frame
Bone mineral density of hip and lumbar spine;

Countries

China

Contacts

Public ContactYao Qi

Peking University Medical Science Center

yqjh2010@163.com+86 13124716445

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026